This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

An ever-increasing population of patients with papillary thyroid cancer is engaging with
health care systems around the world. Numerous questions about optimal management …

Thyroid cancer is the fifth most common cancer in women and represents 3.1% of all new
cancer cases in the United States. 1, 2 Currently, an estimated 53,990 new cases of thyroid …

Background: The American Thyroid Association (ATA) management guidelines for patients
with thyroid nodules and differentiated thyroid cancer (DTC) are highly influential practice …

Background The incidence of papillary thyroid cancer has increased substantially during the
past 15 years, which is likely related to an increased detection of small, nonlethal cancers …

Background: Current guidelines allow lobectomy as treatment for 1–4 cm papillary thyroid
carcinomas (PTCs), as previous studies reported no clear survival advantages for total …

Background Recent guidelines advocate unilateral thyroidectomy for low‐risk 1‐cm to 4‐cm
differentiated thyroid cancer (DTC). This study was designed to examine the association …

Background Total thyroidectomy (TT) is recommended by guidelines for intermediate-risk
papillary thyroid carcinoma (PTC) but its survival advantage over lobectomy has not been …

Introduction Differentiated thyroid cancer (DTC) is the most common of endocrine cancers.
Many studies have focused on recurrence-free survival of DTC patients, however, few …

Background Thyroid cancer patients report unmet needs after diagnosis. However, little is
known about their specific needs. Therefore, we sought to characterize the needs of patients …